Current o/s count includes series a and b warrants. I didn't take that into acct in my prior review of share structure. Additional shrs will depend on prices received on sales of ATM shares. There is $50M ATM outstanding if recollection serves. Assuming a conservative $2/shr would add 25m shrs. So 170M+ shrs o/s compared to my prior estimate of ~220M shrs prior to fda clearance.
News 
Market Data 
Discover 
AI
